FDA approves treatment for patients with a type of inflammatory arthritis - FDA Press Releases

The FDA is approving Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis. This is the first time that the FDA has approved a treatment for non-radiographic axial spondyloarthritis (nr-axSpA). nr-axSpA is a type of inflammatory arthritis that causes inflammation in the spine and other symptoms

from Food and Drug Administration--Press Releases https://ift.tt/2Yw7e2i
via IFTTT